Milestone Pharmaceuticals
Milestone is a drug development company developing novel small molecule therapeutics based on clinically validated mechanisms for cardiovascular diseases. Milestone’s lead product is a novel and potent short-acting calcium channel antagonist for the systemic treatment of transient cardiovascular conditions such as atrial arrhythmias and angina.
Our partnership
Milestone Pharma is a BDC Capital Healthcare Venture Fund company, co-managed in partnership by Amplitude Venture Capital.
Contact
Dion Madsen, Founding partner at Amplitude Venture Capital.
Investment year: 2012
Industry sector: Drugs
Region: Quebec
Website
Recent news
2017-08-01
Milestone Pharmaceuticals Closes $55 Million Series C Financing
Learn More
View All News
Certain news link to external sites and are presented in French only.